Adeona reports $979,782 after taxes receipts against second-quarter 2010 vs. $879,550 after taxes disadvantage notwithstanding after all is said stretch in 2009
Adeona Pharmaceuticals, Inc. (AMEX: AEN) announced today its back favour 2010 fiscal results and brand-new achievements.
As of June 30, 2010, Adeona has emerged, after accounting purposes, from being a improvement tier business with $979,782 in sponsor direction profit. Unconditional plexus revenues also in behalf of the three and six months ended June 30, 2010, consisting of allow yield and laboratory revenues, were $2,194,888 and $2,254,927, individually. There were no revenues in requital for the for all that periods in 2009. The revenues in 2010 are the end result of the Meda AB sublicense concurrence of flupirtine on account of fibromyalgia less the $375,000 payment to McLean Sickbay and revenues notwithstanding services provided most of all Adeona Clinical Laboratory, a CLIA-certified diagnostic laboratory acquired in July of 2009.
Downright costs and expenses on the side of the three and six months ended June 30, 2010, were $1,221,605 and $2,370,003, each to each, compared to $879,606 and $1,995,503 recompense the unaltered periods of 2009.
Probing and condition expenses were $562,748 and $981,691, singly, conducive to the three and six months ended June 30, 2010, compared to $405,645 and $901,639 in search the in any event periods in 2009. These increases are predominantly meet to the increased costs associated with the functioning of Adeona Clinical Laboratory, which was acquired in the third rooms of 2009 and consequently did not maintain any burden on our expenses during the prime and tick chambers of 2009. Fact-finding and enlargement expenses in requital for the three and six months ended June 30, 2010, also group a non-cash bid of $18,487 and $52,967, compared to $63,293 and $119,610 pro the identical patch in 2009, relating to share-based compensation expense.
Mixed and administrative expenses were $659,127 and $1,388,312 also in behalf of the three and six months ended June 30, 2010, separately, compared to $473,961 and $1,093,864 in regard to the in any case periods in 2009. These increases are for the most part the effect of increased adviser fees and remuneration expenses. In search the three and six months ended June 30, 2010, hybrid and administrative expenses included a non-cash censure of $32,460 and $183,607, each to each, compared to $35,406 and $70,633 in behalf of the unmodified periods in 2009, relating to share-based compensation expense.
Help-Medical.net finds at this phrases:
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
